World Generic Medicines Congress Europe 2012 - list of speakers 

Dr. Jack Aurora is Ph.D. in pharmaceutical sciences with over 19 years of Quality and Compliance driven research and management experience to his credit. Dr. Aurora’s research experience is in all the dosage forms including but not limiting to solids, semi-solids, liquids and sterile with special emphasis for Novel Drug Delivery Systems including...

Jesús Carrasco Abad is a Director in the Heathcare team at RBS. He is responsible for investment banking coverage of Generics / Specialty Pharma across Europe and has, amongst other, recently advised ratiopharm on their sale to Teva. Prior to joining ABN AMRO, now RBS, Jesús was a Strategy Consultant to the Pharmaceutical Industry. Jesús has more...

Guy joined Goldshield in August 2010 as Business Development Director, with responsibility for strengthening the strategic development of this UK-based specialty pharma company. The company was acquired by a Private Equity firm (HgCapital) in December 2010 and Guy is responsible for identifying and implementing the strategic plan, business...

A considerable part of my career was spent with AstraZeneca Plc as a analytical / research chemist before moving into the commercial field of procurement and supply chain for them. This transfer from a technical to a commercial application has taken me In the past to work for Smith & Nephew Plc, Powderject, Chiron Vaccines and SSL International...

Frances graduated from Magdalen, Oxford, in Biochemistry and immediately joined Savory Milln as a UK pharmaceuticals analyst. Following its takeover by Swiss Bank Corporation, she took up a role in pan-European pharmaceuticals coverage at IMI before moving to Nomura in 1994. At Nomura, she initially specialised in central European pharmaceuticals...

After graduating from ELTE School of Law of Budapest, Paul Csiszár studied international comparative law and earned a second JD at Loyola Law School in the United States. Following his admission to the bar in 1986 in California he practiced as a corporate, securities and M&A lawyer in the US and then from 1997 in Central Europe with the...

Dr. Cornelius Erbe is currently holding a position as senior vice president and member of the extended Board of Deutsche Angestellten-Krankenkasse (DAK); Hamburg/Germany. DAK is the third largest German statutory health insurance organization with 4.4 million members and 5.6 million insurants. Dr. Erbe is head of Product Management and is...

Since November 2008 Michael Ewers is Managing Director/CEO of betapharm Arzneimittel GmbH in Augsburg, which is a subsidiary of the international pharmaceutical company Dr. Reddy's Laboratories, headquartered in Hyderabad, India. Ewers started his professional career in the pharmaceutical industry in 1986 at Merz+Co. as a junior product...

Rahul Garella is an experienced pharmaceutical executive with more than fifteen years of experience in the pharmaceutical business across the segments of Active pharmaceutical ingredients (APIs) and generic formulations. He currently heads up the European generics business for Glenmark Generics Europe Limited and is involved in setting up...

John has over 23 years’ experience in the Pharmaceutical and technology industry in supply chain management and efficiency. John now provides expert consulting in the areas of Supply Chain Management, Operations, Strategy and Systems to clients in the Pharmaceutical, Medical Device, Premium Drink, Healthcare Distribution and Private Equity sectors ...

Dominic is a Vice Chairman of Rothschild in London and also holds the position of Global Head of Healthcare. He has been at Rothschild since 1998. As an experienced M&A practitioner focused on the healthcare industry, he has a long track record of completed healthcare transactions. Within the pharma / generics sector, Dominic has advised, inter ...

Graduated from the University of Athens as a Chemist and has an impressive thirty seven-year career in Pharmaceutical Operations, first working for 13 years for Greek national companies before joining Bristol Myers Squibb in 1986 in a key Quality Assurance position. He was rapidly promoted in BMS into site management roles and then into multi site ...

Work Experience Jun 2011 to Present Group Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jul 2009 - Jun 2011 Senior Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jan 2007 – Jul 2009 Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jan 2002 - Jan 2007 Product...

Michael Kotsanis has over 20 years of experience in the pharmaceutical industry and has significant senior leadership experience across the global pharmaceutical markets. He is the Chief Commercial Officer for Synthon, a position he has held since mid 2010. Synthon is a fast growing specialty pharmaceutical company based in The Netherlands and is...

ANISH MEHTA has been with Watson Pharmaceuticals for 2 years and serves as the Vice President of European Generics. In this role, he is responsible for managing and growing Watson’s European Generics business. Prior to joining Watson, Mr. Mehta held a series of management positions with Baxter Healthcare, including Senior Director of...

Paul Mendelsohn has over 20 years of experience in the Pharmaceutical Industry, working internationally to develop and grow companies and has over 15 years experience in licensing globally having completed several hundred product /country deals. Founder and Managing Director of Pharmawise Ltd , a consultancy business specialising in the Generic...

Accomplished Pharmaceutical Professional with more than fifteen years of Global Pharmaceutical Marketing and Management experience. Proficient in all areas relating to Pharmaceutical business with a successful performance record throughout. First hand business management exposure in Europe, CIS, MENA and Asia. Has worked with Ranbaxy, Intas and...

Andreas received his Doctorate in Artificial Intelligence (AI) from Strathclyde University in the UK. In the twenty-five years since graduating, Andreas has built technology development teams at EU corporations in the engineering, software and telecoms fields. Andreas is an expert reviewer and evaluator for the European Commission and the Austrian ...

Juliana Reed is the Vice President of Government Affairs for Hospira, Inc where she has overall responsibility for the Government Relations function which includes the oversight of global government relations and public policy initiatives for the corporation. As the first U.S.-based company to launch a biosimilar product in Europe, Retacrit®...

Gregor Siebert is Vice President Hospital Europe and Emerging Markets, EPBU. The unit is responsible for maximizing value creation in the worldwide hospital and sterile injectables market for Pfizer. Gregor’s responsibilities include the implementation of branded hospital injectables and generics in the Emerging Markets and Europe. Gregor´s...

Dr Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade. Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional...

Mr. Togo is the Deputy General Manager, Management Planning Development Department of Towa Pharmaceutical Co., Ltd. He started his business career in Yoshitomi Pharmaceutical (Existing Mitsubishi Tanabe Pharma Corporation) as a medicinal chemist in 1991. He was engaged in several mergers and acquisitions as assistant manager and manager of...

Dr. Aman Trehan is head of Global Intellectual Property at Pharmaceutical Technology Centre of Zydus Cadila Healthcare Ltd. He obtained his doctorate in Pharmaceutical Sciences from Panjab University, India. He has worked in various multinational pharma companies of repute i.e. Ranbaxy, Wockhardt, Alembic. He has undergone various specialized...

Representative Henry A. Waxman represents California's 30th Congressional District, which includes the cities of Santa Monica, Beverly Hills, Agoura Hills, Calabasas, Hidden Hills, Malibu, Westlake Village and West Hollywood, as well as such areas of Los Angeles as Beverly-Fairfax, Pacific...

Peter Wittner, B.Sc., is an independent consultant specialising in the commercial aspects of generics with more than 30 years’ pharmaceutical experience. Before starting his own business, Peter headed the European sales and marketing departments of the UK generics companies Evans Medical and H.N. Norton, which later became part of IVAX. He later...